BIOCRYST PHARMACEUTICALS INC (BCRX) Stock Income Statement
NASDAQ:BCRX - US09058V1035 - Common Stock
8.31 USD
-0.16 (-1.89%)
8.28 USD
-0.03 (-0.36%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 557.51M | 450.71M | 331.41M | 270.80M | 157.20M | |||
| Cost Of Goods | 16.73M | 12.48M | 4.66M | 6.60M | 7.30M | |||
| Gross Profit | 540.78M | 438.23M | 326.75M | 264.20M | 149.90M | |||
| Operating Expenses | 486.58M | 440.77M | 428.91M | 412.70M | 327.60M | |||
| Research and Development | 171.18M | 174.64M | 215.02M | 253.30M | 208.80M | |||
| Selling, General, and Administrative Expenses | 315.41M | 266.13M | 213.89M | 159.40M | 118.80M | |||
| Operating Income | 54.20M | -2.54M | -102.16M | -148.40M | -177.70M | |||
| Interest Income/Expense | -82.22M | -84.41M | -93.50M | -95.90M | -59.90M | |||
| Non Recurring Items | N/A | 0.00 | -30.57M | 0.00 | 55.80M | |||
| Income Before Taxes | -32.19M | -86.95M | -226.23M | -244.40M | -181.80M | |||
| Income Tax | 3.52M | 1.93M | 310.00K | 2.70M | 2.30M | |||
| Net Income | -35.71M | -88.88M | -226.54M | -247.10M | -184.10M | |||
| EBITDA | 55.48M | -1.30M | -100.51M | -146.96M | -176.92M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.17 | -0.43 | -1.18 | -1.33 | -1.03 | |||
| Non GAAP EPS | -0.16 | -0.43 | -0.99 | -1.33 | -1.03 | |||
| Statistics | ||||||||
| Gross Profit Margin | 97.00% | 97.23% | 98.59% | 97.56% | 95.36% | |||
| Profit Margin | -6.41% | -19.72% | -68.36% | -91.25% | -117.11% | |||
| Operating Profit Margin | 9.72% | -0.56% | -30.83% | -54.80% | -113.04% | |||
All data in USD